Nautilus Biotechnology, Inc. <NAUT.O>: Leerink Partners initiates coverage with outperform rating; price target $4
NAUT•Related News
Manchester United to report fiscal Q4 2026 results
MANU•
Il Makiage parent Oddity Tech's Q2 profit beats on SpoiledChild brand growth
ODD•
Ouster, Flyability to showcase lidar inspection partnership at INTERGEO
OUST•
Bank Of Montreal - BMO Investorline Introduces Unlimited $0 Commissions On Stock And ETF Trades
BMO•
Summit Therapeutics Inc. <SMMT.O>: Jefferies raises to Buy from Hold; raises target price to $25 from $15
SMMT•